MarkDavidLogsdonMD

PubMed

• 11 citations
  Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial.
  Thomas J. Quinn, Stephanie Daignault-Newton, Walter R. Bosch, Neil Mariados, John Sylvester, Dhiren Shah, Eric Gross, Richard Hudes, David C. Beyer, Steven Kurtzman, J...> ;Practical Radiation Oncology. 2020 May 1
• 37 citations
  Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial.
  Daniel A. Hamstra, Neil Mariados, John Sylvester, Dhiren Shah, Eric Gross, Richard Hudes, David C. Beyer, Steven Kurtzman, Jeffrey A. Bogart, R. Alex Hsi, Michael Kos,...> ;Practical Radiation Oncology. 2018 Jan 1
• 231 citations
  Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial
  Daniel A. Hamstra, Neil Mariados, John Sylvester, Dhiren Shah, Lawrence Karsh, Richard Hudes, David C. Beyer, Steven Kurtzman, Jeffrey A. Bogart, R. Alex Hsi, Michael ...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Apr 1
• 248 citations
  Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostat...
  Neil Mariados, John Sylvester, Dhiren Shah, Lawrence Karsh, Richard Hudes, David C. Beyer, Steven Kurtzman, Jeffrey A. Bogart, R. Alex Hsi, Michael Kos, Rodney J. Elli...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Aug 1
• 30 citations
  On using 3D γ-analysis for IMRT and VMAT pretreatment plan QA.
  Chuan Wu, Kelly E. Hosier, Kristen E. Beck, Marlyn B. Radevic, Joerg Lehmann, Hao H. Zhang, Aaron Kroner, Sharon C. Dutton, Seth A. Rosenthal, Jonathan K. Bareng, Mark...> ;Medical Physics. 2012 Jun 1
• 9 citations
  LOW DOSE RATE BRACHYTHERAPY IN THE TREATMENT OF CERVICAL CARCINOMA
  Mark D. Logsdon, Patricia J. Eifel> ;Hematology/oncology Clinics of North America. 1999 Jun 1
• 15 citations
  Apoptosis and the BCL-2 gene family - patterns of expression and prognostic value in STAGE I and II follicular center lymphoma
  Mark D Logsdon, Raymond E. Meyn, Pelayo C. Besa, William C. Pugh, L. Clifton Stephens, Lester J. Peters, Luka Milas, James D. Cox, Fernando Cabanillas, Shawn Brisbay, ...> ;International Journal of Radiation Oncology, Biology, Physics. 1999 Apr 1
• 208 citations
  Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
  Mark D Logsdon, Patricia J. Eifel> ;International Journal of Radiation Oncology, Biology, Physics. 1999 Mar 1
• 10 citations
  Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix
  Arthur W. Chaney, Patricia J. Eifel, Mark D Logsdon, Mitchell Morris, J. Taylor Wharton> ;International Journal of Radiation Oncology, Biology, Physics. 1998 Jan 1
• 104 citations
  Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy
  Mark D Logsdon, Chul S. Ha, Vivek S. Kavadi, Fernando Cabanillas, Mark A. Hess, James D. Cox> ;Cancer. 1997 Aug 1
• 53 citations
  Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
  Henry K. Lee, Anastasios Georgiou, Mark D. Logsdon, Peter P. Lai, Mary Ann Lockett, Carlos A. Perez> ;International Journal of Radiation Oncology, Biology, Physics. 1993 Jul 15
• Join now to see all